이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Wearable Sensors and Video-Based Testing to Track Arm Function After Treatment for Neurogenic Thoracic Outlet Syndrome

2026년 11월 13일 업데이트: Bryan M. Burt, MD, FACS, University of California, Los Angeles

Remote Assessment and Digital Biomarker-Based Testing for Neurogenic Thoracic Outlet Syndrome: Longitudinal Follow-up After Physical Therapy or Surgery (Study 2)

The goal of this study is to learn whether wearable motion sensors and video-based movement analysis can track changes in arm function over time in adults with neurogenic thoracic outlet syndrome (NTOS) who are receiving standard treatment (physical therapy or surgery).

NTOS happens when nerves between the neck and shoulder are squeezed, causing pain, numbness, weakness, and trouble using the arm. There is currently no objective test to measure how severe NTOS is or how well treatment is working.

The main questions this study aims to answer are:

  • Can digital measurements of arm movement, collected with wearable sensors and with standard webcam video, detect changes in arm function after NTOS treatment?
  • Are these digital measurements more sensitive to change than standard questionnaires?
  • Do video-based measurements agree with sensor-based measurements?
  • Can measurements taken before treatment help predict who will improve with physical therapy?

This study does not assign or change treatment. Physical therapy or surgery is chosen by each participant's doctors as part of usual care.

Participants will:

  • Complete 5 study visits over about 12 months: before treatment and 1 and 2 months after treatment (in clinic), and 6 and 12 months after treatment (remote telemedicine visits)
  • At each visit, perform a short arm movement task (the "Press Test," a 20-second hand-over-head exercise) while wearing motion sensors and/or being recorded on video
  • Complete questionnaires about arm function, pain, mood, and overall health

연구 개요

상태

아직 모집하지 않음

상세 설명

Neurogenic thoracic outlet syndrome (NTOS) is a disorder of dynamic compression of the brachial plexus between the first rib and the scalene muscles. Diagnosis currently relies on subjective clinical assessment, and there are no objective measures to monitor response to treatment. This study evaluates a remote patient monitoring platform that extracts digital biomarkers of upper extremity motor function from the Press Test, a 20-second repetitive hand-over-head task designed to provoke NTOS symptoms.

This is a single-site, prospective longitudinal study at the UCLA Thoracic Outlet Syndrome Center. Adults with a treating-physician diagnosis of NTOS who are proceeding with standard-of-care treatment (physical therapy and/or surgery) are followed for 12 months. Treatment selection is made by the treating clinicians and is not assigned by the study. Approximately 50 participants undergoing physical therapy and 50 undergoing surgery will be enrolled.

At each of five time points (baseline 0-1 month before treatment; 1, 2, 6, and 12 months after treatment), participants perform the Press Test while digital biomarkers are captured with wearable inertial sensors and with AI-based analysis of standard webcam video. The baseline, 1-month, and 2-month assessments are performed in person; the 6- and 12-month assessments are performed remotely via secure telehealth, with sensors provided in clinic or mailed to the participant with written instructions and staff support. Patient-reported outcomes (DASH, VAS pain, Zung Self-Rating Depression Scale, and PROMIS Global Health) are collected at each time point. Feasibility and acceptability of remote assessment are evaluated through visit completion rates, time burden, technical issues, and a technology acceptance questionnaire.

Analyses will use linear and generalized linear mixed models to assess change over time, intraclass correlation coefficients and Bland-Altman analyses to compare sensor- and video-derived measures, and exploratory models to identify baseline predictors of response to physical therapy.

This study is funded by the National Institutes of Health (R01HD121303).

연구 유형

관찰

등록 (추정된)

100

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 (성인)

건강한 자원 봉사자를 받아들입니다

해당 없음

연구 대상 성별

모두

샘플링 방법

비확률 샘플

연구 인구

Adults aged 18 to 60 years with a treating-physician diagnosis of neurogenic thoracic outlet syndrome who are evaluated at the UCLA Thoracic Outlet Syndrome Center and are proceeding with standard-of-care physical therapy or surgery.

설명

Inclusion Criteria:

  • Men or women aged 18 to 60 years
  • Treating-physician diagnosis of neurogenic thoracic outlet syndrome (NTOS)
  • Plan for standard-of-care treatment (physical therapy and/or surgery) at UCLA
  • Right-handed, left-handed, or ambidextrous
  • Able to provide informed consent and complete study activities

Exclusion Criteria:

  • Bilateral NTOS
  • Previous surgery for NTOS at any time, or NTOS-directed physical therapy within the past 2 months
  • Venous thoracic outlet syndrome
  • Arterial thoracic outlet syndrome
  • NTOS together with another condition affecting the upper extremity
  • Cognitive impairment
  • Acute or chronic conditions unrelated to NTOS that may affect upper extremity function (e.g., stroke, Parkinson's disease, arthritis, cancer)
  • History of drug or alcohol abuse within the past 6 months
  • Inability to participate in follow-up assessments (e.g., plans to move out of state within 12 months, or inability to complete remote follow-up visits)

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 관찰 모델: COHORT
  • 시간 관점: PROSPECTIVE

코호트 및 개입

그룹/코호트
Physical Therapy

Adults with neurogenic thoracic outlet syndrome whose treating physician has recommended standard-of-care physical therapy. Participants complete digital biomarker assessments (Press Test with wearable sensors and webcam video) and patient-reported outcome questionnaires before treatment and at 1, 2, 6, and 12 months after treatment. Treatment is not assigned by the study.

Surgery

Adults with neurogenic thoracic outlet syndrome whose treating physician has recommended standard-of-care surgical decompression (e.g., first rib resection, scalenectomy, and brachial plexus neurolysis). Participants complete digital biomarker assessments (Press Test with wearable sensors and webcam video) and patient-reported outcome questionnaires before treatment and at 1, 2, 6, and 12 months after treatment. Treatment is not assigned by the study.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Change in Press Test Digital Biomarkers of Upper Extremity Function
기간: Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

Digital biomarkers of upper extremity motor function (representing slowness, weakness, rigidity, exhaustion, and unsteadiness, e.g., speed, power, rise time, and range of motion) extracted from a 20-second repetitive hand-over-head Press Test using wearable inertial sensors and AI-based webcam video analysis. Change from baseline will be assessed at each follow-up time point.

Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
Change in Disabilities of the Arm, Shoulder and Hand (DASH) Score
기간: Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

The DASH is a 30-item self-reported questionnaire of upper extremity disability and symptoms. Scores range from 0 to 100; higher scores indicate greater disability.

Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

2차 결과 측정

결과 측정
측정값 설명
기간
Change in Pain Intensity (Visual Analog Scale)
기간: Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

Self-reported pain intensity on a 0 to 10 visual analog scale; higher scores indicate worse pain.

Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
Change in Zung Self-Rating Depression Scale (SDS) Score
기간: Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

20-item self-reported depression scale. Raw scores range from 20 to 80; higher scores indicate more severe depressive symptoms.

Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
Change in PROMIS Global Health Physical and Mental Health T-Scores
기간: Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

PROMIS Global Health v1.2 (10 items) yields Global Physical Health and Global Mental Health T-scores (population mean 50, SD 10); higher scores indicate better health.

Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
Agreement Between Sensor-Based and Video-Based Digital Biomarkers
기간: Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

Agreement between digital biomarkers derived from wearable sensors and from AI-based webcam video analysis during the Press Test, assessed by intraclass correlation coefficient (ICC) at each time point.

Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
Baseline Digital Biomarkers as Predictors of Response to Physical Therapy
기간: Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

Performance of machine learning models using pre-treatment digital biomarkers, demographics, and clinical factors to predict non-response to physical therapy (no meaningful symptom improvement), reported as area under the ROC curve (AUC).

Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 11월 20일

기본 완료 (추정된)

2030년 11월 1일

연구 완료 (추정된)

2031년 11월 1일

연구 등록 날짜

최초 제출

2026년 11월 13일

QC 기준을 충족하는 최초 제출

2026년 11월 13일

처음 게시됨 (실제)

2026년 11월 19일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 19일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 13일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • IRB-26-0380-Study2
  • R01HD121303 (미국 NIH 보조금/계약)

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다